Drug Trial Radar · NCT02513550
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Jun 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,257
Actual
Start
Aug 2015
Primary completion
Nov 2016
Study completion Aug 3, 2017
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jul 31, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy of ixekizumab dosing regimens in participants with plaque psoriasis.
Conditions
- Plaque Psoriasis
Interventions
IxekizumabDrug
Administered SQ
PlaceboDrug
Administered SQ
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Static Physician Global Assessment (sPGA) of (0,1)Time frame: Week 52
- Percentage of Participants Achieving 75% Improvement in Psoriasis Area and Severity Index (PASI 75)Time frame: Week 52
Locations
125 sites in 14 countries. Site status is shown where the registry gives one.
Total Skin and Beauty Dermatology Center PC
Birmingham, Alabama
Anaheim Clinical Trials, LLC
Anaheim, California
David Stoll, M.D.
Beverly Hills, California
Dermatology Research Associates
Los Angeles, California
Center for Dermatology and Laser Surgery
Sacramento, California
Medical Center for Clinical Research
San Diego, California
University Clinical Trials, Inc.
San Diego, California
Clinical Science Institute
Santa Monica, California
Cherry Creek Research, Inc
Denver, Colorado
Florida Academic Dermatology Centers
Coral Gables, Florida
Avail Clinical Research LLC
DeLand, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Renstar Medical Research
Ocala, Florida
Ameriderm Research
Ormond Beach, Florida
University of South Florida
Tampa, Florida
Advanced Medical Research
Atlanta, Georgia
University Dermatology
Darien, Illinois
Deaconess Clinic Inc
Evansville, Indiana
Dawes Fretzin Clinical Research
Indianapolis, Indiana
The South Bend Clinic
South Bend, Indiana
Kansas City Dermatology, PA
Overland Park, Kansas
Heartland Research Associates
Wichita, Kansas
Dermatology Specialist
Louisville, Kentucky
Dr. Shondra Smith MD
Lake Charles, Louisiana
DermAssociates, P.C.
Rockville, Maryland
ActivMed Practices & Research, Inc
Beverly, Massachusetts
Central Dermatology PC
St Louis, Missouri
ActivMed Practices & Research, Inc
Newington, New Hampshire
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey
Academic Dermatology Associates
Albuquerque, New Mexico
Mount Sinai School of Medicine Dermatology Clinical Trials
New York, New York
Skin Search of Rochester, Inc
Rochester, New York
University of North Carolina Dermatology and Skin Cancer Center
Chapel Hill, North Carolina
PMG Research of Wilmington, LLC
Wilmington, North Carolina
Wilmington Dermatology Center
Wilmington, North Carolina
Piedmont Medical Research
Winston-Salem, North Carolina
University Hospitals of Cleveland
Cleveland, Ohio
Healthcare Research Consultant
Tulsa, Oklahoma
Oregon Dermatology and Research Center
Portland, Oregon
Oregon Medical Research Center
Portland, Oregon
Showing 40 of 125 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.